Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.
2.

Advances in pneumococcal disease prevention: 13-valent pneumococcal conjugate vaccine for infants and children.

Paradiso PR.

Clin Infect Dis. 2011 May;52(10):1241-7. doi: 10.1093/cid/cir142. Review.

PMID:
21507921
4.
5.

Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults.

Durando P, Faust SN, Fletcher M, Krizova P, Torres A, Welte T.

Clin Microbiol Infect. 2013 Oct;19 Suppl 1:1-9. doi: 10.1111/1469-0691.12320. Review.

6.

Summary of invasive pneumococcal disease burden among children in the Asia-Pacific region.

Lin TY, Shah NK, Brooks D, Garcia CS.

Vaccine. 2010 Nov 10;28(48):7589-605. doi: 10.1016/j.vaccine.2010.07.053. Epub 2010 Aug 1. Review.

PMID:
20674872
7.

Pneumococcal serotype evolution in Western Europe.

Tin Tin Htar M, Christopoulou D, Schmitt HJ.

BMC Infect Dis. 2015 Oct 14;15:419. doi: 10.1186/s12879-015-1147-x. Review.

8.

Global prevailing and emerging pediatric pneumococcal serotypes.

McIntosh ED, Reinert RR.

Expert Rev Vaccines. 2011 Jan;10(1):109-29. doi: 10.1586/erv.10.145. Review.

PMID:
21162625
9.

Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae.

Dagan R.

Clin Microbiol Infect. 2009 Apr;15 Suppl 3:16-20. doi: 10.1111/j.1469-0691.2009.02726.x. Review.

10.

Epidemiological changes after PCV7 implementation in Italy: perspective for new vaccines.

Ansaldi F, de Florentis D, Canepa P, Bandettini R, Diana MC, Martini M, Durando P, Icardi G.

Hum Vaccin. 2011 Jan-Feb;7 Suppl:211-6. doi: 10.4161/hv.7.0.14602. Review.

PMID:
21546795
11.

Effectiveness of the 7-valent pneumococcal conjugate vaccine against vaccine-type invasive disease among children in Uruguay: an evaluation using existing data.

Picón T, Alonso L, García Gabarrot G, Speranza N, Casas M, Arrieta F, Camou T, Rosa R, De Oliveira LH, Verani JR.

Vaccine. 2013 Jul 2;31 Suppl 3:C109-13. doi: 10.1016/j.vaccine.2013.01.059. Review.

PMID:
23777683
12.

Improving the protection against Streptococcus pneumoniae with the new generation 13-valent pneumococcal conjugate vaccine.

Durando P, Alicino C, De Florentiis D, Martini M, Icardi G.

J Prev Med Hyg. 2012 Jun;53(2):68-77. Review.

PMID:
23240163
13.

13-valent pneumococcal conjugate vaccine (PCV13).

Jefferies JM, Macdonald E, Faust SN, Clarke SC.

Hum Vaccin. 2011 Oct;7(10):1012-8. doi: 10.4161/hv.7.10.16794. Epub 2011 Oct 1. Review.

PMID:
21941097
14.

Can the success of pneumococcal conjugate vaccines for the prevention of pneumococcal diseases in children be extrapolated to adults?

Weil-Olivier C, Gaillat J.

Vaccine. 2014 Apr 11;32(18):2022-6. doi: 10.1016/j.vaccine.2014.02.008. Epub 2014 Feb 22. Review.

PMID:
24565755
15.

Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis.

Balsells E, Guillot L, Nair H, Kyaw MH.

PLoS One. 2017 May 9;12(5):e0177113. doi: 10.1371/journal.pone.0177113. eCollection 2017. Review.

16.

13-valent pneumococcal conjugate vaccine: a review of its use in infants, children, and adolescents.

Plosker GL.

Paediatr Drugs. 2013 Oct;15(5):403-23. doi: 10.1007/s40272-013-0047-z. Review.

PMID:
24030738
17.

The pneumococcal conjugate vaccine.

Jacobson RM, Poland GA.

Minerva Pediatr. 2002 Aug;54(4):295-303. Review.

PMID:
12131865
18.

Introduction of pneumococcal conjugate vaccine into the public immunization program in South Africa: translating research into policy.

Madhi SA, Cohen C, von Gottberg A.

Vaccine. 2012 Sep 7;30 Suppl 3:C21-7. doi: 10.1016/j.vaccine.2012.05.055. Review.

PMID:
22939016
19.

The impact of 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease: a literature review.

Myint TT, Madhava H, Balmer P, Christopoulou D, Attal S, Menegas D, Sprenger R, Bonnet E.

Adv Ther. 2013 Feb;30(2):127-51. doi: 10.1007/s12325-013-0007-6. Epub 2013 Feb 7. Review.

PMID:
23397399
20.

Lessons learnt after the introduction of the seven valent-pneumococcal conjugate vaccine toward broader spectrum conjugate vaccines.

Falup-Pecurariu O.

Biomed J. 2012 Nov-Dec;35(6):450-6. doi: 10.4103/2319-4170.104409. Review.

Supplemental Content

Support Center